Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

Withdrawn before enrolling · Phase 1

Conditions studied: Transient Ischemic Attack, Stroke, Aspirin, Clopidogrel

In brief

Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

Key facts

Study ID

NCT00363753

Run by

University of California, San Diego

People needed

0

Starts

2006-08-01

Expected to finish

2007-03-01

Last updated by the study team

2019-08-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 and older.
• Stroke or transient ischemic attack (TIA) while taking aspirin within one week of consent.
• Women of child-bearing potential will be included only if there is a negative pregnancy test and they agree to birth control during the treatment period.

You may not qualify if…

• Any medical indication for a specific antiplatelet agent (aspirin, clopidogrel, ticlopidine, aggrenox), or an indication for a combination of antiplatelet agents.
• Any medical indication for anticoagulation, except subcutaneous heparin for deep vein thrombosis prophylaxis.
• Allergy to aspirin or clopidogrel.

Where it is running

• UCSD Hillcrest — San Diego, California, United States
• UCSD — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.